QACV to Attend the 4th Annual mRNA-Based Therapeutics Summit

QACV Consulting will be participating as an exhibit sponsor at the upcoming mRNA-Based Therapeutics Summit which will be held July 29-31^st at the Westin Boston Seaport District Hotel. Visit the QACV booth to discuss how QACV may be able to assist your Quality, Compliance and Validation needs, including compliance audits, data integrity support, QA/compliance staffing, CMC, and validation services. Additionally, QACV will  present a poster which will feature QACV’s risk-based approach using data mapping processes to ensure data integrity in the development and manufacture of mRNA-based therapies.

The event, which will also feature sessions and panel discussions from experts in the field including representatives from the FDA, EMA and leaders from industry, will showcase mRNA technology. This technology has come to the forefront of drug development since the adoption of mRNA-based COVID-19 vaccines just over three years ago.  QACV has helped to support several clients in the mRNA therapeutics space in recent years and has been actively onboarding consultants who have considerable background working with mRNA therapies. QACV is eager to help accelerate these novel therapies into clinical trials and eventually to the market by offering its GxP consulting services to companies with a footprint in this exciting field.